Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ · Healthcare
Orchestra BioMed Holdings, Inc. EPS 2022–2025
Orchestra BioMed Holdings, Inc. annual/quarterly eps history and growth rate from 2022 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Orchestra BioMed Holdings, Inc. eps for the quarter ending March 31, 2026 was $0.33, a 32.65% decrease year-over-year.
- Orchestra BioMed Holdings, Inc. annual eps for 2025 was $1.11, a 33.13% decrease from 2024.
- Orchestra BioMed Holdings, Inc. annual eps for 2024 was $1.66, a 12.16% increase from 2023.
- Orchestra BioMed Holdings, Inc. annual eps for 2023 was $1.48, a 33.93% decrease from 2022.
- Orchestra BioMed Holdings, Inc. annual eps for 2022 was $2.24.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Orchestra BioMed Holdings, Inc. EPS — FAQ
Orchestra BioMed Holdings, Inc. (OBIO) eps over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Orchestra BioMed Holdings, Inc.'s eps?
Orchestra BioMed Holdings, Inc. (OBIO) reported eps of $-1.11 for fiscal 2025.
Where can I see OBIO's eps history?
The chart and table above show Orchestra BioMed Holdings, Inc.'s eps by year and by quarter, including the growth rate.